XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Jun. 28, 2024
Jun. 30, 2023
Cash flows from operating activities of Continuing Operations:    
Net income from Continuing Operations $ 139,640 $ 338,765
Adjustments to reconcile Net income from Continuing Operations to Net cash used in operating activities of Continuing Operations    
Depreciation and amortization 322,794 307,083
Asset write-downs 0 27,781
Reduction of contingent consideration liability (see Note 14) 0 (73,891)
Gain on Sale of Equity Investments, net 0 (375,972)
Deferred income taxes (11,948) 89,760
Share-based compensation expense 46,895 56,872
Changes in operating assets and liabilities    
Receivables (236,390) (178,606)
Inventories 27,632 (7,438)
Prepayments and Other Current Assets (3,548) (16,449)
Accounts Payable (224,211) (274,844)
Accrued Expenses (353,730) (246,933)
Payments made to clients on contracts (108,262) (103,798)
Other operating activities 106,027 42,663
Net cash used in operating activities of Continuing Operations (295,101) (415,007)
Cash flows from investing activities of Continuing Operations:    
Purchases of property and equipment and other (288,140) (258,585)
Disposals of property and equipment 17,228 12,956
Purchases of marketable securities (71,215) (69,998)
Proceeds from marketable securities 71,215 40,000
Acquisition of certain businesses, net of cash acquired (106,334) (49,503)
Proceeds from sale of equity investments 0 633,179
Other investing activities (2,158) 15,455
Net cash (used in) provided by investing activities of Continuing Operations (379,404) 323,504
Cash flows from financing activities of Continuing Operations:    
Proceeds from long-term borrowings 298,329 1,550,886
Payments of long-term borrowings (1,591,906) (1,807,652)
Net change in funding under the Receivables Facility 599,000 395,065
Payments of dividends (74,853) (85,898)
Proceeds from issuance of common stock 24,872 42,343
Other financing activities (56,006) (18,578)
Net cash (used in) provided by financing activities of Continuing Operations (800,564) 76,166
Discontinued Operations:    
Net cash provided by operating activities 0 144,914
Net cash used in investing activities 0 (41,598)
Net cash used in financing activities 0 (19,431)
Net cash provided by Discontinued Operations 0 83,885
Effect of foreign exchange rates on cash and cash equivalents and restricted cash (1,769) 13,268
(Decrease) Increase in cash and cash equivalents and restricted cash (1,476,838) 81,816
Cash and cash equivalents and restricted cash, beginning of period 1,972,367 365,431
Cash and cash equivalents and restricted cash, end of period 495,529 447,247
Supplemental disclosure of cash flow information    
Interest paid 267,300 322,200
Income taxes paid 90,300 37,300
Balance Sheet classification    
Cash and cash equivalents 436,075 388,166
Restricted cash in Prepayments and other current assets 59,454 44,833
Cash and cash equivalents in Current assets of discontinued operations 0 14,248
Total cash and cash equivalents and restricted cash $ 495,529 $ 447,247